- Home
- SOND vs TRIB Comparison
SOND vs TRIB Comparison
Compare SOND & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOND
- TRIB
- Stock Information
- Founded
- SOND 2014
- TRIB 1992
- Country
- SOND United States
- TRIB Ireland
- Employees
- SOND N/A
- TRIB N/A
- Industry
- SOND Hotels/Resorts
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SOND Consumer Discretionary
- TRIB Health Care
- Exchange
- SOND Nasdaq
- TRIB Nasdaq
- Market Cap
- SOND 26.5M
- TRIB 25.5M
- IPO Year
- SOND N/A
- TRIB N/A
- Fundamental
- Price
- SOND $1.98
- TRIB $0.57
- Analyst Decision
- SOND
- TRIB
- Analyst Count
- SOND 0
- TRIB 0
- Target Price
- SOND N/A
- TRIB N/A
- AVG Volume (30 Days)
- SOND 22.1K
- TRIB 36.7K
- Earning Date
- SOND 04-08-2025
- TRIB 05-22-2025
- Dividend Yield
- SOND N/A
- TRIB N/A
- EPS Growth
- SOND N/A
- TRIB N/A
- EPS
- SOND N/A
- TRIB N/A
- Revenue
- SOND $624,458,000.00
- TRIB $59,126,000.00
- Revenue This Year
- SOND $28.50
- TRIB $11.63
- Revenue Next Year
- SOND $17.62
- TRIB $10.13
- P/E Ratio
- SOND N/A
- TRIB N/A
- Revenue Growth
- SOND 8.32
- TRIB N/A
- 52 Week Low
- SOND $0.88
- TRIB $0.56
- 52 Week High
- SOND $10.50
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- SOND 30.90
- TRIB 34.26
- Support Level
- SOND $2.00
- TRIB $0.63
- Resistance Level
- SOND $2.45
- TRIB $0.71
- Average True Range (ATR)
- SOND 0.18
- TRIB 0.05
- MACD
- SOND -0.00
- TRIB -0.01
- Stochastic Oscillator
- SOND 1.66
- TRIB 3.66
About SOND Sonder Holdings Inc.
Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests. The Company also provides accommodations to travelers through boutique hotels.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.